In summary, our results suggest the fascinating possibility that RANKL and its downstream signaling molecule, integrin α2, may be indicators of tumorigenesis in HNSCC and are attractive functional markers for this malignancy. This evidence concerns the gene TNFSF11 and head and neck squamous cell carcinoma.